AUG 13, 2026 · PHASE 3 TRIAL
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
ClinicalTrials.gov
This is a registry record for an ongoing Phase 3 trial with no results yet reported; the study design is sound but evidence cannot be evaluated until data are available.
Reported
Planned enrollment510
PhasePhase 3
Primary outcome (Trial part)Progression-Free Survival (PFS) from Date o…